1
Clinical Trials associated with Recombinant Flagellin Subunit Campylobacter Vaccine(U.S. Army Medical Research and Development Command)Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers
This study is an open-labeled dose escalating trial in which a total of 32 subjects will receive one of four intranasal rFla-MBP vaccine doses.
100 Clinical Results associated with Recombinant Flagellin Subunit Campylobacter Vaccine(U.S. Army Medical Research and Development Command)
100 Translational Medicine associated with Recombinant Flagellin Subunit Campylobacter Vaccine(U.S. Army Medical Research and Development Command)
100 Patents (Medical) associated with Recombinant Flagellin Subunit Campylobacter Vaccine(U.S. Army Medical Research and Development Command)
100 Deals associated with Recombinant Flagellin Subunit Campylobacter Vaccine(U.S. Army Medical Research and Development Command)